Tech Company Financing Transactions
Eagle Genomics Funding Round
Eagle Genomics, based in London England, scored $20 million from Abrdn, Environmental Technologies Fund and Granpool.
Transaction Overview
Company Name
Announced On
10/31/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The investment will support further development of the e[datascientist]� 2 platform and will continue to drive expansion into global markets and the deepening of client impact.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
36-40 York Way
London England, N1 9AB
UK
London England, N1 9AB
UK
Phone
Website
Email Address
Overview
Eagle Genomics applies network science to biology. We are revealing the impact of the microbiome on humans, animals and the environment to secure a sustainable future for our food, water, soil and the health of our planet. Our mission is to deliver insight from the microbiome to profoundly change our understanding of wellness and even our fundamental assumptions about life on earth.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anthony Finbow
Chief Financial Officer
Gavin Horn
Chief Technical Officer
Radouane Oudrhiri
VP - Engineering
Tarun Rishi
VP - Product Management
Anup Hirani
Browse more venture capital transactions:
Prev: 10/31/2022: OncoPrecision venture capital transaction
Next: 10/31/2022: Topline Pro venture capital transaction
Share this article
News on VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs